Report cover image

Drug Delivery Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published Jan 01, 2025
Length 145 Pages
SKU # FOB19847086

Description

Growth Factors of Drug Delivery Market

The global drug delivery market is experiencing significant growth, driven by the increasing prevalence of chronic diseases, technological advancements, and a shift towards patient-centric healthcare solutions. According ta report by Fortune Business Insights, the market size stood at USD 1,021.29 billion in 2018 and is projected treach USD 1,801.54 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.4% during the forecast period.

Technological Advancements and Digitalization

The pharmaceutical industry is undergoing a transformation with a strong emphasis on digitalization. Manufacturers are integrating digital technologies intdrug delivery systems tenhance patient adherence, wellness, and education. For instance, Insulet Corporation's Omnipod, a wearable device for diabetes management, is designed tbe smart, waterproof, and discreet, providing patients and caregivers with peace of mind.

The trend towards digital health solutions is not only improving therapeutic outcomes but alsensuring that patients receive the proper therapeutic dose for their diagnosed conditions. This shift is driving the need for novel and smart medication delivery systems, such as wearables and connected devices, which offer features like adherence tracking and dosing reminders.

Innovative Product Launches

The introduction of new products with large-volume doses, smart technology, and user-friendly attributes has increased the demand for advanced drug administration systems. The popularity of ocular inserts, insulin jets, wearables, and other innovative products has provided greater efficiency and customer satisfaction. Significant investments by producers in understanding patient needs and introducing products that match these requirements are projected taugment market growth. For example, West Pharmaceutical Services Inc. launched the NovaPure 3ml cartridge for the delivery of higher-volume injectable medicines.

Patient Preference and Home-based Care

There is a rising patient preference for advanced drug administration systems over conventional methods. This shift is anticipated tdrive market growth during the forecast period. The adoption of home-based care and self-administration is increasing, supported by the development of user-friendly devices enabled with smart technology. This trend not only enhances patient convenience but alsreduces the burden on healthcare facilities.

Regional Market Insights

North America dominated the global drug delivery market in 2018, with a market size of USD 428.0 billion. This dominance is attributed tthe increasing number of patients adopting drug delivery devices and the presence of major pharmaceutical companies in the region. Europe held the second-largest market share, driven by the rising penetration of large pharmaceutical companies and the increasing burden of diseases in the region.

Challenges and Restraints

Despite the positive outlook, the market faces challenges such as stringent regulations imposed on the approval of combination drugs. Frequently changing regulatory norms may deter manufacturers from investing heavily in research and development, potentially hindering the introduction of innovative products. Additionally, the high cost of advanced devices and limited reimbursement policies, especially in emerging countries, may limit market adoption.

Future Outlook

The drug delivery market is poised for substantial growth, driven by technological advancements, patient-centric approaches, and the increasing prevalence of chronic diseases. The focus on digitalization and the introduction of smart, user-friendly devices are expected tenhance patient adherence and therapeutic outcomes. However, addressing regulatory challenges and ensuring affordability will be crucial tfully realize the market's potential.

In conclusion, the global drug delivery market is undergoing a significant transformation, with technological innovations and patient preferences shaping its future trajectory. Manufacturers and stakeholders must navigate regulatory landscapes and cost challenges tleverage the opportunities presented by this evolving market.

ATTRIBUTE DETAILS

Study Period - 2015 -2026

Base Year - 2018

Forecast Period - 2019-2026

Historical Period - 2015-2017

Unit Value (USD Billion)

Segmentation By Route of Administration
  • Injectable
  • Inhalation
  • Topical & Transdermal
  • Oral
  • Others
By Type
  • Conventional
  • Advanced
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
By Geography
  • North America (the U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

145 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. New Product Launch
4.2. Pipeline Analysis
4.3. Technological Advancements in the Drug Delivery Market
4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
5. Global Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Route of Administration
5.2.1. Injectable
5.2.2. Inhalation
5.2.3. Topical & Transdermal
5.2.4. Oral
5.2.5. Others
5.3. Market Analysis, Insights and Forecast – By Type
5.3.1. Conventional
5.3.2. Advanced
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Hospital Pharmacies
5.4.2. Retail Pharmacies
5.4.3. Others
5.5. Market Analysis, Insights and Forecast – By Geography
5.5.1. North America
5.5.2. Europe
5.5.3. Asia pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Route of Administration
6.2.1. Injectable
6.2.2. Inhalation
6.2.3. Topical & Transdermal
6.2.4. Oral
6.2.5. Others
6.3. Market Analysis, Insights and Forecast – By Type
6.3.1. Conventional
6.3.2. Advanced
6.4. Market Analysis, Insights and Forecast – By Distribution Channel
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Others
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Route of Administration
7.2.1. Injectable
7.2.2. Inhalation
7.2.3. Topical & Transdermal
7.2.4. Oral
7.2.5. Others
7.3. Market Analysis, Insights and Forecast – By Type
7.3.1. Conventional
7.3.2. Advanced
7.4. Market Analysis, Insights and Forecast – By Distribution Channel
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Others
7.5. Market Analysis, Insights and Forecast – By Country/Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Route of Administration
8.2.1. Injectable
8.2.2. Inhalation
8.2.3. Topical & Transdermal
8.2.4. Oral
8.2.5. Others
8.3. Market Analysis, Insights and Forecast – By Type
8.3.1. Conventional
8.3.2. Advanced
8.4. Market Analysis, Insights and Forecast – By Distribution Channel
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Others
8.5. Market Analysis, Insights and Forecast – By Country/Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Route of Administration
9.2.1. Injectable
9.2.2. Inhalation
9.2.3. Topical & Transdermal
9.2.4. Oral
9.2.5. Others
9.3. Market Analysis, Insights and Forecast – By Type
9.3.1. Conventional
9.3.2. Advanced
9.4. Market Analysis, Insights and Forecast – By Distribution Channel
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Others
9.5. Market Analysis, Insights and Forecast – By Country/Sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Route of Administration
10.2.1. Injectable
10.2.2. Inhalation
10.2.3. Topical & Transdermal
10.2.4. Oral
10.2.5. Others
10.3. Market Analysis, Insights and Forecast – By Type
10.3.1. Conventional
10.3.2. Advanced
10.4. Market Analysis, Insights and Forecast – By Distribution Channel
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Others
10.5. Market Analysis, Insights and Forecast – By Country/Sub-region
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
11.5.1. BD
11.5.1.1. Overview,
11.5.1.2. Products & Services,
11.5.1.3. SWOT Analysis,
11.5.1.4. Recent Developments,
11.5.1.5. Strategies,
11.5.1.6. Financials (Based on Availability)
11.5.2. Emergent Biosolutions Inc.
11.5.2.1. Overview,
11.5.2.2. Products & Services,
11.5.2.3. SWOT Analysis,
11.5.2.4. Recent Developments,
11.5.2.5. Strategies,
11.5.2.6. Financials (Based on Availability)
11.5.3. Consort Medical plc
11.5.3.1. Overview,
11.5.3.2. Products & Services,
11.5.3.3. SWOT Analysis,
11.5.3.4. Recent Developments,
11.5.3.5. Strategies,
11.5.3.6. Financials (Based on Availability)
11.5.4. Aptar Pharma
11.5.4.1. Overview,
11.5.4.2. Products & Services,
11.5.4.3. SWOT Analysis,
11.5.4.4. Recent Developments,
11.5.4.5. Strategies,
11.5.4.6. Financials (Based on Availability)
11.5.5. West Pharmaceutical Services Inc.
11.5.5.1. Overview,
11.5.5.2. Products & Services,
11.5.5.3. SWOT Analysis,
11.5.5.4. Recent Developments,
11.5.5.5. Strategies,
11.5.5.6. Financials (Based on Availability)
11.5.6. Insulet Corporation
11.5.6.1. Overview,
11.5.6.2. Products & Services,
11.5.6.3. SWOT Analysis,
11.5.6.4. Recent Developments,
11.5.6.5. Strategies,
11.5.6.6. Financials (Based on Availability)
11.5.7. Nemera
11.5.7.1. Overview,
11.5.7.2. Products & Services,
11.5.7.3. SWOT Analysis,
11.5.7.4. Recent Developments,
11.5.7.5. Strategies,
11.5.7.6. Financials (Based on Availability)
11.5.8. SHL Medical AG.
11.5.8.1. Overview,
11.5.8.2. Products & Services,
11.5.8.3. SWOT Analysis,
11.5.8.4. Recent Developments,
11.5.8.5. Strategies,
11.5.8.6. Financials (Based on Availability)
11.5.9. Pfizer Inc.
11.5.9.1. Overview,
11.5.9.2. Products & Services,
11.5.9.3. SWOT Analysis,
11.5.9.4. Recent Developments,
11.5.9.5. Strategies,
11.5.9.6. Financials (Based on Availability)
11.5.10. Other Prominent Players
11.5.10.1. Overview,
11.5.10.2. Products & Services,
11.5.10.3. SWOT Analysis,
11.5.10.4. Recent Developments,
11.5.10.5. Strategies,
11.5.10.6. Financials (Based on Availability)
12. Strategic Recommendations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us